aureus by 41% (p = .002) and against E
Semaglutide shots help maintain calorie deficits without the extreme restriction that triggers metabolic compensation
However, both medications can cause gastrointestinal side effects that may be more pronounced when used together, requiring medical monitoring
Understanding the evidence, risk factors, and contraindications helps patients and providers make informed treatment decisions
Noom, an online weight loss company, will now be selling small doses of compounded versions of Wegovy, the prescription medication developed by Novo Nordisk
Important considerations for ongoing treatment: Regular review with the prescribing healthcare professional is essential Treatment should be discontinued if no clear benefit is observed after an adequate trial period (typically 812 weeks) Do not delay seeking medical attention for new or worsening symptoms Be alert to red flag symptoms requiring urgent assessment, such as unexplained weight loss, persistent fever, chest pain, or suicidal thoughts Patients should maintain realistic expectations , recognising that robust evidence for clinical benefits remains limited